Medicine and Dentistry
Bone
100%
Patient
72%
Bone Metastasis
36%
Castration Resistant Prostate Cancer
27%
Prostate Specific Antigen
27%
Lesion
18%
Prostate Cancer
18%
Alkaline Phosphatase Bone Isoenzyme
18%
Therapeutic Procedure
18%
Male
18%
Diseases
9%
Surgery
9%
Radiopharmaceutical Agent
9%
Overall Survival
9%
Disease Exacerbation
9%
Anodyne
9%
Docetaxel
9%
Opiate
9%
External Beam Radiotherapy
9%
Bone Scintigraphy
9%
Isotope
9%
Ketoconazole
9%
Progressive Disease
9%
Bone Pain
9%
Bone Marrow Toxicity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Metastasis
36%
Castration Resistant Prostate Cancer
27%
Prostate Specific Antigen
27%
Case Report
27%
Prostate Cancer
18%
Radiopharmaceutical Agent
9%
Diseases
9%
Overall Survival
9%
Disease Exacerbation
9%
Analgesic Agent
9%
Opiate
9%
Docetaxel
9%
Bone Marrow Toxicity
9%
Isotope
9%
Ketoconazole
9%
Bone Pain
9%
Symptom
9%
Nursing and Health Professions
Bone Metastasis
36%
Castration Resistant Prostate Cancer
27%
Bone Marrow Toxicity
9%
Radiopharmaceutical Agent
9%
Bone Pain
9%
Isotope
9%
Biochemistry, Genetics and Molecular Biology
Prostate-Specific Antigen
27%
Dose
27%
Alkaline Phosphatase
18%
Overall Survival
9%
Time
9%
Opiate
9%
Veterinary Science and Veterinary Medicine